The head author, also the presenting author, is asked to submit the abstract.

※To become a member of the Japan Society of Clinical Oncology (JSCO)

If you wish to become a member of JSCO, please visit the JSCO website for further details.

All abstracts should be submitted through the online abstract submission system. We suggest you to have enough time for abstract submission since the line may be busy a few days before the submission deadline.

※About Abstract Submission System
 JSCO has introduced an abstract submission system for both general and invited speakers starting from JSCO 2014 Congress. This system enables JSCO members to obtain their registered membership data from "My Ganchi" system and reduce time to input personal information when registering abstracts.
 JSCO members are requested to check the registered membership data and update as necessary.

 1. JSCO Members and Applicants 

■General and Invited Speakers

※If you have forgotten your Login ID and Password used for "my ganchi" system, please click here.

 2. JSCO Non-Members 

■General Speakers

※In order to submit your abstracts, you need to include more than one JSCO member as coauthors in your abstracts or belong to an overseas organization.

※For security reasons, we are unable to answer any questions about your passwords.

 ■Invited Speakers

1. General Abstracts
   
   (Doctors - Abstract & Presentation Slides: English, Presentation Language: English or Japanese)
   (Non-doctors - Abstract & Presentation Slides & Presentation Language: English or Japanese)
   (Non-doctors - Abstract & Presentation Slides & Presentation Language: English or Japanese)  * All doctors are requested to submit the abstracts in English.
   • The presentation will be in the form of an oral or poster presentation, and it will be left to the Congress President and the Program Committee Members' discretion.
   (1) Oral Presentation
   
   • Please make a PC-based presentation.
   (2) Poster Presentation
   
   • In order to avoid gatherings during the poster panel presentations, all presentations will be changed to e-poster format. All e-poster data should be submitted in advance. More details regarding e-poster presentations will be announced at a later date.
     We apologize for the inconvenience and thank you for your kind understanding.

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.

From JSCO Annual Meeting in 2007, Clinical Oncology Research Conflict of Interest Policy was established, and in order to secure the fairness of the presentations for clinical research at Annual Meetings, conflicts of interest that presenting authors have been obligated to disclose the COI status from 2008. Moreover, the guideline enforced from April, 2013, which is called "Oncology Research Conflict of Interest Policy "and it applies not only for clinical research, but also all medical studies including bioscience research, basic medical research, clinical trials.

Matters for which disclosure is required shall be matters that occur from two year before abstract submission to the time of presentation; it is provided. Please refer to the COI page on Online Abstract Submission system for details, and mark the boxes which match with your status. The amounts for which self-declaration is required are prescribed for each matter requiring disclosure as follows. Presenting authors who are officers or advisors of companies or for-profit organizations, or the profit from sales of stock, or patent royalties or licensing fees from companies are 1 million yen or more. Honoraria (such as lecture fees) or report manuscript fees paid by a company are 500,000 yen or more. Report research funding is 1,000,000 yen or more. For more details about COI, please refer to JSCO Website.

Please download the COI disclosure PDF sample.

The Congress President and the Program Committee will select excellent abstracts from the submitted general abstracts. The best abstracts will then be chosen from those selected abstracts. The head authors of the best abstracts are requested to make an oral presentation at the Plenary Session either in English or Japanese.

• The Congress President and the Program Committee will select excellent abstracts by thoroughly reviewing the submitted general abstracts.
• The head authors whose abstracts have been selected as excellent abstracts are required to submit the abstract in English, in case the submitted abstracts are in Japanese.
• The excellent abstracts will be posted on the JSCO website.
  On the page for public: Authors' name, affiliation and abstract
  On the page for JSCO members: Authors' name, affiliation, abstract and presentation slides

The presentation style will be decided by the Congress President and the Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

The notification of the abstracts result, presentation style, date and time will be sent to the head authors' registered email address from the Management Secretariat (reg-jsco2020@c-linkage.co.jp) at the end of July.

The copyright of all accepted abstracts will be transferred to JSCO.
The abstracts submitted by the invited speakers will be posted on the JSCO website.

Click the button below to start your abstract submission.
Please note in advance that you will not be able to save the data in middle of the submission procedure.

c/o Convention Linkage, Inc.
2 Sanbancho, Chiyoda-ku, Tokyo 102-0075, Japan
TEL: +81-3-3263-2359
FAX: +81-3-3263-8693
E-mail : reg-jsco2020@c-linkage.co.jp